Table 2.
Correlations of EBV antibodies with clinical characteristics of SjS patients.
| EBV antibodies | Spearman r | P value |
|---|---|---|
| IgG-anti-VCA antibody | ||
| Age | 0.16 | 0.08 |
| ESSDAI | 0.08 | 0.39 |
| C3 | -0.17 | 0.06 |
| C4 | -0.08 | 0.39 |
| IgG-anti-EA antibody | ||
| Age | 0.08 | 0.37 |
| ESSDAI | 0.09 | 0.31 |
| C3 | -0.31 | <0.001* |
| C4 | -0.20 | 0.03* |
| IgG-anti-EBNA1 antibody | ||
| Age | -0.05 | 0.58 |
| ESSDAI | 0.07 | 0.48 |
| C3 | -0.07 | 0.46 |
| C4 | -0.10 | 0.29 |
*Bold values suggested statistically significant findings.